Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
---|---|---|---|---|---|---|---|
Pfizer Inc. | 30 | 4 | 1 | 0 | €26.62 | €40.66 | 52.740% |
Incyte Corp. | 12 | 2 | 3 | 0 | €52.32 | €78.42 | 49.890% |
Gilead Sciences Inc | 11 | 1 | 5 | 0 | €62.47 | €84.81 | 35.764% |
Abbott Laboratories | 16 | 0 | 2 | 0 | €96.50 | €116.81 | 21.044% |
Merck & Co. Inc. | 28 | 1 | 1 | 0 | €120.60 | €124.93 | 3.590% |
AbbVie Inc. | 21 | 0 | 4 | 0 | €151.26 | €174.43 | 15.320% |
Johnson & Johnson | 33 | 1 | 3 | 0 | €141.98 | €196.36 | 38.301% |
Zoetis Inc. A | 23 | 1 | 4 | 0 | €159.92 | €200.06 | 25.098% |
Biogen Inc. | 47 | 1 | 7 | 1 | €211.70 | €294.45 | 39.088% |
Amgen Inc. | 25 | 0 | 5 | 0 | €289.65 | €297.31 | 2.645% |
Vertex Pharmaceuticals Inc. | 45 | 2 | 6 | 0 | €405.60 | €408.36 | 0.680% |
Eli Lilly Corp. | 50 | 0 | 5 | 0 | €710.30 | €766.92 | 7.971% |
Regeneron Pharmaceuticals Inc. | 36 | 1 | 5 | 0 | €890.60 | €958.32 | 7.604% |